Hay fever relief hacks you should know as pollen ‘very high’ across the UK
POLLEN is hard to avoid in the summer months and can make going outside incredibly uncomfortable for hay fever patients. While preventing symptoms can be hard to do, relieving yourself of the relentless side effects such as sneezing and itchiness is easier than you think. (Source: Daily Express - Health)
Source: Daily Express - Health - June 15, 2022 Category: Consumer Health News Source Type: news
Insomnia: Tips for getting to sleep if you suffer from hay fever - expert
IT CAN be difficult to sleep at the best of times. But with the UK experiencing a spate of hot weather as well as a high pollen count, it can be even harder for sufferers of hay fever. (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2022 Category: Consumer Health News Source Type: news
'Thunder fever' warning for millions of hayfever and asthma sufferers this week
A pollen bomb and a potentially record breaking heatwave followed by 'thunder fever' could lead to a week of misery for millions of asthmatics and hay fever suffers. (Source: the Mail online | Health)
Source: the Mail online | Health - June 13, 2022 Category: Consumer Health News Source Type: news
Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
June 10, 2022 (VIENNA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated efficacy and safety results from the teclistamab cohort of the Phase 1b TriMM-2 study (NCT04108195). Teclistamab, an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting B-cell maturation antigen (BCMA) is being studied in combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in patients with relapsed or refractory multiple myeloma (RRMM) who have received three or more prior lines of therapy.1 Patients in the study, including a high proportion with prior anti-CD38 exposur...
Source: Johnson and Johnson - June 10, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma
June 10, 2022 (VIENNA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated results from the Phase 1 MonumenTAL-1 first-in-human dose-escalation study of talquetamab (NCT03399799), an investigational, off-the-shelf, T cell redirecting bispecific antibody targeting both GPRC5D, a novel multiple myeloma target, and CD3 on T cells.1 Results from the study showed encouraging responses in heavily pretreated patients with relapsed or refractory multiple myeloma (RRMM) who received talquetamab at the recommended subcutaneous Phase 2 dose (RP2D) administered weekly (QW) or every two weeks (Q2W).2 The...
Source: Johnson and Johnson - June 10, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
No Needle, No Sneeze: Immunotherapy Option for Allergic Rhinitis No Needle, No Sneeze: Immunotherapy Option for Allergic Rhinitis
Local nasal immunotherapy is an effective and safe alternative treatment for allergic rhinitis, researchers report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 9, 2022 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Suffering hay fever for first time ever this year? Blame Covid lockdowns and global warming
Anecdotally there has been a surge in the number of people suffering from hay fever seemingly out of the blue. And UK Google trends for hay fever are also at a record high. (Source: the Mail online | Health)
Source: the Mail online | Health - June 9, 2022 Category: Consumer Health News Source Type: news
Updated Data for Janssen ’s Bispecific Teclistamab Suggest Continued Deep and Durable Responses in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
CHICAGO, ILLINOIS, June 5, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced updated efficacy and safety results from the teclistamab Phase 1/2 MajesTEC-1 study. Teclistamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting B-cell maturation antigen (BCMA), which is being studied in patients with relapsed or refractory multiple myeloma (RRMM) who have received three or more prior lines of therapy.1 The data were featured as part of an oral session during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Additional poster presentations f...
Source: Johnson and Johnson - June 5, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news
Combining Allergic Rhinitis Treatments May Improve Symptoms Combining Allergic Rhinitis Treatments May Improve Symptoms
If one treatment for allergic rhinitis doesn ' t improve symptoms, combining it with other treatments may work, researchers in Thailand report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 23, 2022 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Hay fever: Cheese and milk could be making your symptoms worse – a dietician's warning
HAY FEVER could have you rubbing your eyes, sneezing, and coughing; many people experience headaches and a blocked nose. Could your diet be making your symptoms worse? (Source: Daily Express - Health)
Source: Daily Express - Health - May 19, 2022 Category: Consumer Health News Source Type: news
Hayfever: Diet 'can play a big part in easing symptoms or making them worse'
HAY FEVER can have a big impact on people, with symptoms sometimes causing constant itchy eyes and headaches. Fortunately, an expert has said what you eat can also help ease symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 19, 2022 Category: Consumer Health News Source Type: news
Achoo! The hay fever season lasts longer than ever. Here ’s what we can do about it | Kate Ravilious
The climate crisis is giving trees a bigger window to spread their pollen, but cleaner air and better early warning forecasts can help protect usIf you have sneezed your way through the last few days, you are not alone. About aquarter of the UK population are thought to suffer from hay fever, with numbers continuing to grow. And thelatest researchsuggests that the climate crisis is going to make the hay fever season a whole lot longer and more intense, with up to three times as much pollen wafting around by the end of the century. Hold on to your antihistamines.For people with lung conditions such as asthma or chronic obst...
Source: Guardian Unlimited Science - May 17, 2022 Category: Science Authors: Kate Ravilious Tags: Hay fever Climate crisis Environment Allergies Society Source Type: news
Eye health tips for high pollen levels
As pollen levels rise and many people across the UK start experiencing hay fever symptoms, The College of Optometrists has issued new member resources and eye health tips to help the public manage their allergies. (Source: NHS Networks)
Source: NHS Networks - May 16, 2022 Category: UK Health Source Type: news
Hay fever: Five ways you can keep symptoms at bay amid treatment shortage
WITH the arrival of Spring and Summer comes the arrival of warmer days and shorter nights. As well as a return to hotter temperatures, thousands have also been plunged once more into the hay fever season. Express.co.uk recently spoke to expert Marlene Hochstrasser about their top tips for dealing with hay fever. (Source: Daily Express - Health)
Source: Daily Express - Health - May 14, 2022 Category: Consumer Health News Source Type: news
